169 related articles for article (PubMed ID: 26322545)
41. Limosilactobacillus fermentum NCU003089 and Lactiplantibacillus plantarum NCU001261, two probiotics with inhibition of Escherichia coli and Cronobacter sakazakii translocation in vitro.
Wei B; Peng Z; Xiao M; Huang T; Zheng W; Xie M; Xiong T
Microb Pathog; 2023 Aug; 181():106216. PubMed ID: 37391100
[TBL] [Abstract][Full Text] [Related]
42. Complete genome analysis of Lactobacillus fermentum YLF016 and its probiotic characteristics.
Zhang L; Ma H; Kulyar MF; Pan H; Li K; Li A; Mo Q; Wang Y; Dong H; Bao Y; Li J
Microb Pathog; 2022 Jan; 162():105212. PubMed ID: 34597776
[TBL] [Abstract][Full Text] [Related]
43. Lactobacillus fermentum UCO-979C beneficially modulates the innate immune response triggered by Helicobacter pylori infection in vitro.
Garcia-Castillo V; Zelaya H; Ilabaca A; Espinoza-Monje M; Komatsu R; Albarracín L; Kitazawa H; Garcia-Cancino A; Villena J
Benef Microbes; 2018 Sep; 9(5):829-841. PubMed ID: 29798705
[TBL] [Abstract][Full Text] [Related]
44. Human oral isolate Lactobacillus fermentum AGR1487 reduces intestinal barrier integrity by increasing the turnover of microtubules in Caco-2 cells.
Anderson RC; Young W; Clerens S; Cookson AL; McCann MJ; Armstrong KM; Roy NC
PLoS One; 2013; 8(11):e78774. PubMed ID: 24244356
[TBL] [Abstract][Full Text] [Related]
45.
Linninge C; Xu J; Bahl MI; Ahrné S; Molin G
Benef Microbes; 2019 Apr; 10(4):413-424. PubMed ID: 30957532
[TBL] [Abstract][Full Text] [Related]
46. Potentiated In Vitro Probiotic Activities of Lactobacillus fermentum LfQi6 Biofilm Biomass Versus Planktonic Culture.
Berkes E; Liao YH; Neef D; Grandalski M; Monsul N
Probiotics Antimicrob Proteins; 2020 Sep; 12(3):1097-1114. PubMed ID: 31828607
[TBL] [Abstract][Full Text] [Related]
47.
Naghmouchi K; Belguesmia Y; Bendali F; Spano G; Seal BS; Drider D
Crit Rev Food Sci Nutr; 2020; 60(20):3387-3399. PubMed ID: 31729242
[TBL] [Abstract][Full Text] [Related]
48. Probiotic potential of lactic acid bacteria isolated from fermented dairy milks on antiproliferation of colon cancer cells.
Thirabunyanon M; Boonprasom P; Niamsup P
Biotechnol Lett; 2009 Apr; 31(4):571-6. PubMed ID: 19116692
[TBL] [Abstract][Full Text] [Related]
49. Selection of potential probiotics with cholesterol-lowering properties for probiotic yoghurt production.
Wongrattanapipat S; Chiracharoenchitta A; Choowongwitthaya B; Komsathorn P; La-Ongkham O; Nitisinprasert S; Tunsagool P; Nakphaichit M
Food Sci Technol Int; 2022 Apr; 28(4):353-365. PubMed ID: 33926303
[TBL] [Abstract][Full Text] [Related]
50. Lactobacillus fermentum isolated from human colonic mucosal biopsy inhibits the growth and adhesion of enteric and foodborne pathogens.
Varma P; Dinesh KR; Menon KK; Biswas R
J Food Sci; 2010; 75(9):M546-51. PubMed ID: 21535608
[TBL] [Abstract][Full Text] [Related]
51. Lactobacillus fermentum ACA-DC 179 displays probiotic potential in vitro and protects against trinitrobenzene sulfonic acid (TNBS)-induced colitis and Salmonella infection in murine models.
Zoumpopoulou G; Foligne B; Christodoulou K; Grangette C; Pot B; Tsakalidou E
Int J Food Microbiol; 2008 Jan; 121(1):18-26. PubMed ID: 18077037
[TBL] [Abstract][Full Text] [Related]
52. The viability of Lactobacillus fermentum CECT5716 is not essential to exert intestinal anti-inflammatory properties.
Rodríguez-Nogales A; Algieri F; Vezza T; Garrido-Mesa N; Olivares M; Comalada M; Riccardi C; Utrilla MP; Rodríguez-Cabezas ME; Galvez J
Food Funct; 2015 Apr; 6(4):1176-84. PubMed ID: 25700085
[TBL] [Abstract][Full Text] [Related]
53. Probiotic Effects of
Yang D; Lyu W; Hu Z; Gao J; Zheng Z; Wang W; Firrman J; Ren D
Front Nutr; 2021; 8():705763. PubMed ID: 34262929
[TBL] [Abstract][Full Text] [Related]
54. Functional characteristics of Lactobacillus fermentum F1.
Zeng XQ; Pan DD; Zhou PD
Curr Microbiol; 2011 Jan; 62(1):27-31. PubMed ID: 20490496
[TBL] [Abstract][Full Text] [Related]
55. Safety and efficacy of human breast milk Lactobacillus fermentum CECT 5716. A mini-review of studies with infant formulae.
López-Huertas E
Benef Microbes; 2015; 6(2):219-24. PubMed ID: 25519525
[TBL] [Abstract][Full Text] [Related]
56. In vitro immunomodulatory activity of Lactobacillus fermentum CECT5716 and Lactobacillus salivarius CECT5713: two probiotic strains isolated from human breast milk.
Pérez-Cano FJ; Dong H; Yaqoob P
Immunobiology; 2010 Dec; 215(12):996-1004. PubMed ID: 20219262
[TBL] [Abstract][Full Text] [Related]
57. The molecular mechanisms of probiotic strains in improving ageing bone and muscle of d-galactose-induced ageing rats.
Hor YY; Ooi CH; Lew LC; Jaafar MH; Lau AS; Lee BK; Azlan A; Choi SB; Azzam G; Liong MT
J Appl Microbiol; 2021 Apr; 130(4):1307-1322. PubMed ID: 32638482
[TBL] [Abstract][Full Text] [Related]
58. Probiotic Ferulic Acid Esterase Active Lactobacillus fermentum NCIMB 5221 APA Microcapsules for Oral Delivery: Preparation and in Vitro Characterization.
Tomaro-Duchesneau C; Saha S; Malhotra M; Coussa-Charley M; Kahouli I; Jones ML; Labbé A; Prakash S
Pharmaceuticals (Basel); 2012 Feb; 5(2):236-48. PubMed ID: 24288090
[TBL] [Abstract][Full Text] [Related]
59. Limosilactobacillus fermentum, Current Evidence on the Antioxidant Properties and Opportunities to be Exploited as a Probiotic Microorganism.
Paulino do Nascimento LC; Lacerda DC; Ferreira DJS; de Souza EL; de Brito Alves JL
Probiotics Antimicrob Proteins; 2022 Oct; 14(5):960-979. PubMed ID: 35467236
[TBL] [Abstract][Full Text] [Related]
60. Oral supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-hydroxyvitamin D: a post hoc analysis of a randomized controlled trial.
Jones ML; Martoni CJ; Prakash S
J Clin Endocrinol Metab; 2013 Jul; 98(7):2944-51. PubMed ID: 23609838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
